Sodium-Glucose Co-Transporter 2 Inhibitors Reduce Macular Edema in Patients with Diabetes mellitus .
Tomoaki TatsumiToshiyuki OshitariYoko TakatsunaRyoichi IshibashiMasaya KoshizakaYuki ShikoTakayuki BabaKoutaro YokoteShuichi YamamotoPublished in: Life (Basel, Switzerland) (2022)
These findings indicate that systemic SGLT2i can reduce DMEs, and they suggest that SGLT2i may be an additional treatment option to anti-VEGF treatments for eyes with DMEs.